BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 20469779)

  • 41. [Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice - safety and efficacy in basal bolus regimen)].
    Zďarská DJ; Brož J; Křivská B; Rušavý Z; Kvapil M
    Vnitr Lek; 2014 Sep; 60(9):712-9. PubMed ID: 25294758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modified release terbutaline (SKP1052) for hypoglycaemia prevention: a proof-of-concept study in people with type 1 diabetes mellitus.
    Nosek L; Cardot JM; Owens DR; Ibarra P; Bagate K; Vergnault G; Kaiser K; Fischer A; Heise T
    Diabetes Obes Metab; 2012 Dec; 14(12):1137-44. PubMed ID: 22988932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin detemir: A historical perspective on a modern basal insulin analogue.
    Meneghini L; Liebl A; Abrahamson MJ
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S31-42. PubMed ID: 20394890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens.
    Vinagre I; Sánchez-Hernández J; Sánchez-Quesada JL; María MÁ; de Leiva A; Pérez A
    Endocrinol Nutr; 2013 May; 60(5):249-53. PubMed ID: 23523346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes.
    Farrokhi F; Klindukhova O; Chandra P; Peng L; Smiley D; Newton C; Pasquel F; Fereira ME; Umpierrez G
    J Diabetes Sci Technol; 2012 Sep; 6(5):1022-9. PubMed ID: 23063027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutral protamine hagedorn/regular insulin in the treatment of inpatient hyperglycemia: Comparison of 3 basal-bolus regimens.
    Quintanilla-Flores DL; González-González JG; García-De la Cruz G; Tamez-Pérez HE
    World J Diabetes; 2017 Oct; 8(10):455-463. PubMed ID: 29085572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adolescents on basal-bolus insulin can fast during Ramadan.
    Al-Khawari M; Al-Ruwayeh A; Al-Doub K; Allgrove J
    Pediatr Diabetes; 2010 Mar; 11(2):96-100. PubMed ID: 19947956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can a protocol for glycaemic control improve type 2 diabetes outcomes after gastric bypass?
    Fenske WK; Pournaras DJ; Aasheim ET; Miras AD; Scopinaro N; Scholtz S; le Roux CW
    Obes Surg; 2012 Jan; 22(1):90-6. PubMed ID: 22052198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry.
    Gitt AK; Bramlage P; Binz C; Krekler M; Plate T; Deeg E; Tschöpe D;
    Eur J Prev Cardiol; 2012 Aug; 19(4):765-72. PubMed ID: 21628353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Introduction of New South Wales adult subcutaneous insulin-prescribing chart in a tertiary hospital: its impact on inpatient glycaemic control.
    Wong VW; Ho A; Fiakos E; Lau NS; Russell H
    Intern Med J; 2016 Nov; 46(11):1323-1328. PubMed ID: 27549573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of parenteral nutrition associated hyperglycaemia: a comparison of subcutaneous and intravenous insulin regimen.
    Neff K; Donegan D; MacMahon J; O'Hanlon C; Keane N; Agha A; Thompson C; Smith D
    Ir Med J; 2014 May; 107(5):141-3. PubMed ID: 24908857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446].
    Cavan DA; Ziegler R; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Wagner RS
    BMC Fam Pract; 2012 Oct; 13():102. PubMed ID: 23062116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of protocol-guided scheduled basal-nutritional-correction insulin over standard care for vascular surgery patients.
    Harbin M; Dossa A; de Lemos J; Drummond I; Paty B; Taylor B
    Can J Diabetes; 2015 Jun; 39(3):210-5. PubMed ID: 25639852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utility of initial bolus insulin in the treatment of diabetic ketoacidosis.
    Goyal N; Miller JB; Sankey SS; Mossallam U
    J Emerg Med; 2010 May; 38(4):422-7. PubMed ID: 18514472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Designer insulins regimens in clinical practice--pilot multicenter Indian study.
    Joshi SR; Kalra S; Badgandi M; Rao YS; Chawla M
    J Assoc Physicians India; 2005 Sep; 53():775-9. PubMed ID: 16334621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
    Noh RM; Graveling AJ; Frier BM
    Expert Opin Pharmacother; 2011 Oct; 12(14):2161-75. PubMed ID: 21668402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Rydén L; Wedel H; Vestberg D; Lind M
    Eur Heart J; 2013 Feb; 34(5):374-9. PubMed ID: 23144046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetes.
    Buysman E; Conner C; Aagren M; Bouchard J; Liu F
    Curr Med Res Opin; 2011 Sep; 27(9):1709-17. PubMed ID: 21740289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).
    Umpierrez GE; Smiley D; Jacobs S; Peng L; Temponi A; Mulligan P; Umpierrez D; Newton C; Olson D; Rizzo M
    Diabetes Care; 2011 Feb; 34(2):256-61. PubMed ID: 21228246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.